The polymerase chain reaction (PCR) market is anticipated to grow with a CAGR of ~7% over the forecast period of 2019-2028. According to a study published by Insure Insights on the polymerase chain reaction (PCR) market, the increasing investments in the research and development, and rise in the geriatric population are some of the driving factors for the growth of the market. Additionally, an increasing number of diagnostic centers, increasing awareness among the individuals are considered as fueling factors for the growth of the market.

Top Driver: Increase in the Number of Infectious Disease Patients and Enhancement in the Infrastructure of Diagnostic Centers are Driving the Polymerase Chain Reaction (PCR), Market

The polymerase chain reaction (PCR) is a type of laboratory technique that is used for making millions or billions of copies of DNA within a test tube. These techniques are used in several fields including medicine, biotechnology, genetics, and others. The rise in infectious diseases such as HIV, HCV, HBV, HAV, parvovirus B19 (B19V), and on occasion hepatitis E (HEV) are considered as a major factor that is driving the growth of PCR market across the globe. Furthermore, the increasing criminal activities, individual’s identification, child verification are increasing the demand for PCR in the forensic department for identifying the criminal which is also contributing to the growth of the market. Moreover, the increase in awareness among the individuals and the rise in the number of diagnostic centers across the globe is anticipated to drive the growth of the market.

The companies and government are also investing in the PCR market for the development of new technology and medicine for developing a cure for infectious disease. Similarly, the rise in the aging population across the globe is also increasing the risk of several diseases, thus to overcome the loss of life the PCR is used for finding a solution.

Real-time PCR to Make Crucial Contribution to the Growth of Global Polymerase Chain Reaction (PCR) Market  

Based on the type the polymerase chain reaction (PCR) market has been segmented as standard PCR, real-time PCR, and digital PCR. The real-time PCR holds the largest share for the type segment in polymerase chain reaction market this is due to increasing technological advancement and increasing demand for real-time results for research and development, diagnostic centers. Furthermore, the increase in the automation of technology, labs, and utilization of robots is also driving the growth of the market.

Based on end-users, the global polymerase chain reaction (PCR) market has been segmented as hospitals & clinics, pharmaceutical & biotechnology industries, diagnostic centers, and academic & research organizations.  The pharmaceutical & biotechnology industries hold the largest share in the end-user segment due to an increase in investments made for the development of advanced technologies. Furthermore, the requirement for new medicines and the development of drugs plays a vital role in driving the market.

Established Healthcare Industry in North America is Driving the Market

North America has well-developed facilities and infrastructure as compared to other regions. The various pharmaceutical companies, research and development centers, healthcare companies and well-established hospitals, clinics, and other healthcare manufacturing units are leading to drive the growth of the market. Additionally, a rise in geriatric population in the region is further fueling the growth of the market. Based on countries the North American region has been segmented as the US and Canada. The increasing technological advancement in the countries and increasing investments for drug development of infectious disease are few driving factors for the market.

Players to Focus on Expanding Applications in the Healthcare Industry

The global polymerase chain reaction (PCR) market is expected to grow with a significant CAGR due to presence of various companies Agilent Technologies, Thermo Fisher Scientific, bioMérieux SA, Becton, Dickinson and Company, QIAGEN N.V., F. Hoffmann-La Roche AG Inc., Abbott, Siemens Healthcare GmbH (Siemens AG) and others which are developing new products to drive the market growth.

Asuragen Inc.: In January 2019, the Asuragen Inc. which is a molecular diagnostics company launched a simple detection test kit named AmplideX PCR/CE HTT Kit for Huntington’s Diseases. This kit was introduced for providing a highly-sensitive, rapid, and scalable solution for their molecular diagnostics laboratory.

Bio-Rad Laboratories, Inc.: Bio-Rad Laboratories, Inc. a life science research and clinical diagnostic-based company launched CFX Maestro software for real-time PCR data analysis. This software enables the researcher to process the test with ease while reducing the excessive time taken manually.

Scope of the Report

By Type

• Standard PCR
• Real-time PCR
• Digital PCR

By Product

• Instruments
• Reagents & Consumables

By Indication

• Infectious Diseases
• Oncology
• Genetic Disorders
• Others

By End-User

• Hospitals & Clinics
• Pharmaceutical & Biotechnology Industries
• Diagnostic Centers
• Academic & Research Organizations

By Region

• North America
• Europe
• Asia Pacific
• Rest of the World

Key Reasons to Purchase this Report

1. It provides a technological development map over time to understand the growth rate of the industry.
2. The report offers a dynamic method to various factors that drive or restrain the growth of the market.
3. It renders definite analysis for changing competitive dynamics.
4. It builds a seven-year estimate based on how the market is predicted to grow.